Failure to vaccinate Medicare inpatients: A missed opportunity

Archives of Internal Medicine

Volumn 162, Issue 20, 2002, Pages 2349-2356

  Bratzler, Dale W ^a   Houck, Peter M ^b   Jiang, Hui ^a   Nsa, Wato ^a   Shook, Claudette ^a   Moore, Lori ^a   Red, Lisa ^a  

^a Oklahoma Foundation for Medical Quality   (United States)

^b Centers for Medicare and Medicaid Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELDERLY CARE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MEDICARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; VACCINATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INFLUENZA, HUMAN; INPATIENTS; MALE; MEDICARE; PNEUMOCOCCAL INFECTIONS; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; VACCINATION;

EID: 0037111790     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.20.2349     Document Type: Article

References (87)

1. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among persons aged≥65 years - United States, 1999. MMWR Morb Mortal Wkly Rep. 2001;50:532-537.
2. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep. 2001;50(No. RR-4):1-46.
3. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46(No. RR-8):1-24.
4. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults: Infectious Diseases Society of America. Clin Infect Dis. 2000;31:347-382.
5. Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA. 2001;285:1729-1735.
6. Centers for Disease Control and Prevention. Adult immunization programs in nontraditional settings: Quality standards and guidance for program evaluation - A report of the National Vaccine Advisory Committee. MMWR Morb Mortal Wkly Rep. 2000;49(No. RR-1):1-14.
7. Minino AM, Smith BL. Preliminary data for 2000. National Vital Statistics Reports. Vol 49. Hyattsville, Md: National Center for Health Statistics; 2001:No. 12.
8. Fedson DS, Houck P, Bratzler D. Hospital-based influenza and pneumococcal vaccination: Sutton's law applied to prevention. Infect Control Hosp Epidemiol. 2000;21:692-699.
9. Fedson DS, Wajda A, Nicol JP, Roos LL. Disparity between influenza vaccination rates and risks for influenza-associated hospital discharge and death in Manitoba in 1982-1983. Ann Intern Med. 1992;116:550-555.
10. Fedson DS, Baldwin JA. Previous hospital care as a risk factor for pneumonia: Implications for immunization with pneumococcal vaccine. JAMA. 1982;248:1989-1995.
11. Fedson DS, Chiarello LA. Previous hospital care and pneumococcal bacteremia: Importance for pneumococcal immunization. Arch Intern Med. 1983;143:885-889.
12. Fedson DS. Improving the use of pneumococcal vaccine through a strategy of hospital-based immunization: A review of its rationale and implications. J Am Geriatr Soc. 1985;33:142-150.
13. Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiring pneumococcal infections. Arch Intern Med. 1986;146:2179-2185.
14. Fedson DS, Harward MP, Reid RA, Kaiser DL. Hospital-based pneumococcal immunization: Epidemiologic rationale from the Shenandoah study. JAMA. 1990;264:117-122.
15. Centers for Disease Control and Prevention. Use of standing orders programs to increase adult vaccination rates: Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mort Wkly Rep. 2000;49(No. RR-1):15-26.
16. Centers for Disease Control and Prevention. Missed opportunities for pneumococcal and influenza vaccination of Medicare pneumonia inpatients - 12 Western States, 1995. MMWR Morb Mortal Wkly Rep. 1997;46:919-923.
17. Metersky ML, Fine JM, Tu GS, et al. Lack of effect of a pneumonia clinical pathway on hospital-based pneumococcal vaccination rates. Am J Med. 2001;110:141-143
18. Dexter PR, Perkins S, Overhage JM, et al. A computerized reminder system to increase the use of preventive care for hospitalized patients. N Engl J Med. 2001;345:965-970.
19. Jencks SF, Cuerdon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels. JAMA. 2000;284:1670-1676.
20. Centers for Medicare & Medicaid Services. Quality Improvement Organizations (QlOs). National Improvement Priorities. Hospital-Based Projects. Available at: www.cms.hhs.gov/qio/lal.asp. Accessed August 14, 2002.
21. Centers for Disease Control. Prevention and control of influenza: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep. 1986;35:317-326.
22. Centers for Disease Control. Pneumococcal polysaccharide vaccine: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep. 1989;38:38-46.
23. Centers for Disease Control. Public health burden of vaccine-preventable disease among adults: Standards of adult immunization practice. MMWR Morb Mortal Wkly Rep. 1990;39:725-729.
24. American College of Physicians Task Force on Adult Immunization. Guide for Adult Immunization 2nd Ed. Philadelphia, Pa: American College of Physicians; 1990.
25. Association for Practitioners of Infection Control. Position paper: Immunizations. Am J Infect Control. 1992;20:131-132.
26. Fedson DS. Adult immunization: A summary report for the National Vaccine Advisory Committee. JAMA. 1994;272:1133-1137.
27. Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Guideline for prevention of nosocomial pneumonia, Infect Control Hosp Epidemiol. 1994;15:587-627.
28. American Hospital Association Technical Panel on Infections Within Hospitals. Management advisory - Health care delivery: Immunization. Am J Infect Control. 1994;22:42-46.
29. Health Care Financing Administration. Evidence Report and Evidence-Based Recommendations: Interventions that Increase the Utilization of Medicare-Funded Preventive Services for Persons Age 65 and Older. Baltimore, Md: US Dept of Health and Human Services, Health Care Financing Administration; 1999. Publication HCFA-02151.
30. Association for Professionals in Infection Control and Epidemiology. Position paper: Immunizations. Am J Infect Control. 1999;27:52-53
31. Task Force on Community Preventive Services. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med. 2000;18(suppl):92-140.
32. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730-1754..
33. Centers for Disease Control and Prevention: Race-specific differences in influenza vaccination levels among Medicare beneficiariesUnited States, 1993. MMWR Morb Mortal Wkly Rep 1995;44:24-27.
34. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among adults aged>65 years - United States, 1997. MMWR Morb Mortal Wkly Rep. 1998;47:797-802.
35. Schneider EC, Cleary PD, Zaslavsky AM, Epstein AM. Racial disparity in influenza vaccination: Does managed care narrow the gap between African Americans and whites? JAMA. 2001;286:1455-1460.
36. Centers for Disease Control and Prevention. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinationsUnited States, 1996. MMWR Morb Mortal Wkly Rep. 1999;48:886-890.
37. Nichol KL, MacDonald R, Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med. 1996;11:673-677.
38. Gene J, Espinola A, Cabezas C, etal. Do knowledge and attitudes about influenza and its immunization affect the likelihood of obtaining immunization? Fam Pract Res J. 1992;12:61-73.
39. Oehlert WH, Natt S, Nguyen L, et al. Improving influenza and pneumococcal immunizations in Oklahoma: Preliminary results of a survey of Medicare beneficiaries. J Okla State Med Assoc. 2001;94:461-468.
40. Armstrong K, Berlin M, Schwartz S, Propert K, Ubel PA. Barriers to influenza immunization in a low-income urban population. Am J Prev Med. 2001;20:21-25.
41. Foster DA, Talsma AN, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol. 1992;136:296-307.
42. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: Cost-effectiveness in a health maintenance organization. Ann Intern Med. 1994;121:947-952.
43. Nichol KL, Margolis KL, Wuorenma J, von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778-784.
44. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. Efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature. Ann Intern Med. 1995;123:518-527.
45. Nichol KL, Margolis KL, Wouremna J, von Sternberg T. Effectiveness of influenza vaccine in the elderly. Gerontology. 1996;42:274-279.
46. Nichol KL, Goodman M. The health and economic benefits of influenza vaccination for health and at-risk persons aged 65 to 74 years. Pharmacoeconomics. 1996;16(suppl 1):63-71.
47. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 1998;158:1769-1776.
48. Nguyen-Van-Tam JS, Neal KR. Clinical effectiveness, policies, and practices for influenza and pneumococcal vaccines. Semin Respir Infect. 1999;14:184-195.
49. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999;130:397-403.
50. Berry BB, Ehlert DA, Battiola RJ, Sedmak G. Influenza vaccination is safe and immunogenic when administered to hospitalized patients. Vaccine. 2001;19:3493-3498.
51. Brydak LB, Roszkowska-Blaim M, Machala M, Leszczynska B, Sieniawska M. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine. 2000;18:3280-3286.
52. Flanders S. Pneumococcal vaccination prior to hospital discharge. In: Shojania KG, Duncan BW, McDonald KM, et al, eds. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Evidence Report/Technology Assessment No. 43 (chap 36), AHRQ Publication 01 -E058. Rockville, Md: Agency for Healthcare Research and Quality. July 2001. Available at: http://www.ahrq.gov/clinic /ptsafety/chap36.htm. Accessed April 8, 2002.
53. Shapiro ED, Clemens JD. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann Intern Med. 1984;101:325-330.
54. Sims RV, Steinmann WC, McConville JH, etal. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med. 1988;108:653-657.
55. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325:1453-1460.
56. Butler JC, Breiman RF, Campbell JF, et al. Polysaccharide pneumococcal vaccine efficacy: An evaluation of current recommendations. JAMA. 1993;270:1826-1831.
57. Farr BM, Johnston BL, Cobb DK, et al. Preventing pneumococcal bacteremia in patients at risk: Results of a matched case-control study. Arch Intern Med. 1995;155:2336-2340.
58. Butler JC, Shapiro ED, Carlone GM. Pneumococcal vaccines: History, current status, and future directions. Am J Med. 1999;107(suppl 1A):69S-76S.
59. Ortqvist A, Hedlund J, Burman L, et al. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet. 1998;351:399-403.
60. Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults: A meta-analysis of randomized controlled trials. Arch Intern Med. 1994;154:2666-2677.
61. Hutchison BG, Oxman AD, Shannon HS, et al. Clinical effectiveness of pneumococcal vaccine: Meta-analysis. Can Fam Physician. 1999;45:2381-2393.
62. Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med. 1999;159:2437-2442.
63. Christenson B, Lundbergh P, Hedlund J, Ortqvist A. Effects of a large-scale im intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years and older: A prospective study. Lancet. 2001;357:1008-1011.
64. Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine. 1991;17(suppl 1):S91-S93.
65. Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremias among unvaccinated nursing home residents. N Engl J Med. 1998;338:1861-1868.
66. Bleich S, Morad Y, Echague R, et al. Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: Report and review of recent outbreaks. Infect Control Hosp Epidemiol. 2000;21:711-717.
67. Centers for Disease Control and Prevention. Outbreak of pneumococcal pneumonia among unvaccinated residents of a nursing home - New Jersey, April 2001. MMWR Morb Mortal Wkly Rep. 2001;50:707-710.
68. Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1961-1963.
69. Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA. 1997;278:1333-1339.
70. Centers for Medicare and Medicaid Services. 2001 Fact Sheet for Medicare Influenzal/Pneumococcal Vaccination Benefits. Available at: http://cms.hhs .gov/preventiveservices/2.asp#1. Accessed April 8, 2002.
71. Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly. JAMA. 1990;264:1139-1141.
72. Govaert ME, Dinant GJ, Aretz K, et al. Adverse reactions to influenza vaccine in elderly people: Randomised double blind placebo trial. BMJ. 1993;307:988-990.
73. Jackson LA, Benson P, Sneller VP, et al. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA. 1999;281:243-248.
74. Snow R, Babish JD, McBean AM. Is there any connection between a second pneumonia shot and hospitalization among Medicare beneficiaries? Public Health Rep. 1995;110:720-725.
75. Klein RS, Adachi N. Pneumococcal vaccine in the hospital: Improved use and implications for high-risk patients. Arch Intern Med. 1983;143:1878-1881.
76. Magnussen CR, Valenti WM, Mushlin AI. Pneumococcal vaccine strategy: Feasibility of a vaccination program directed at hospitalized and ambulatory patients. Arch Intern Med. 1984;144:1755-1757.
77. Klein RS, Adachi N. An effective hospital-based pneumococcal immunization program. Arch Intern Med. 1986;146:327-329.
78. Bloom HG, Bloom JS, Krasnoff L, Frank AD. Increased utilization of influenza and pneumococcal vaccines in an elderly hospitalized population. J Am Geriatr Soc. 1988;36:897-901.
79. Clancy CM, Gelfman D, Poses RM. A strategy to improve the utilization of pneumococcal vaccine. J Gen Intern Med. 1992;7:14-18.
80. Crouse BJ, Nichol K, Peterson DC, Grimm MB. Hospital-based strategies for improving influenza vaccination rates. J Fam Pract, 1994;38:258-261.
81. Landis S, Scarbrough ML. Using a vaccine manager to enhance in-hospital vaccine administration. J Fam Pract. 1995;41:364-369.
82. Nichol KL. Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults. Am J Med. 1998;105:385-392.
83. Vondracek TG, Pham TP, Huycke MM. A hospital-based pharmacy intervention program for pneumococcal vaccination. Arch Intern Med. 1998;158:1543-1547.
84. Rodriquez RM, Baraff LJ. Emergency department immunization of the elderly with pneumococcal and influenza vaccines. Ann Emerg Med. 1993;22:1729-1732.
85. Slobodkin D, Kitlas J, Zielske P. Opportunities not missed: Systematic influenza and pneumococcal immunization in a public inner-city emergency department. Vaccine. 1998;16:1795-1802.
86. Popovic JR. 1999 National Hospital Discharge Survey: Annual summary with detailed diagnosis and procedure data: National Center for Health Statistics. Vital Health Stat. 2001;13(151).
87. Fiebach NH, Viscoli CM. Patient acceptance of influenza vaccination. Am J Med. 1991;91:393-400.